Loading: 100%
MEDICAL TRANSCRIPTION BILLING, CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 2,050 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker MTBCno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1701234
datesClosing price (adj.)
13.10.20173.29
11.10.20173.29
04.10.20173.25
27.09.20171.43
20.09.20171.49
13.09.20171.40
06.09.20171.38
30.08.20171.39
23.08.20171.47
16.08.20171.47
09.08.20171.40
02.08.20172.15
26.07.20171.23
19.07.20171.18
12.07.20171.25
05.07.20171.43
27.06.20171.49
20.06.20171.52
13.06.20171.54
06.06.20171.76
30.05.20172.07
23.05.20172.09
16.05.20172.04
09.05.20171.96
02.05.20172.00
25.04.20170.44
18.04.20170.54
11.04.20170.54
04.04.20170.68
28.03.20170.65
21.03.20170.63
14.03.20170.69
07.03.20170.76
28.02.20170.68
21.02.20170.77
14.02.20170.78
07.02.20170.72
31.01.20170.75
24.01.20170.80
17.01.20170.72
10.01.20170.72
03.01.20170.66
27.12.20160.87
19.12.20160.83
12.12.20160.84
05.12.20160.86
28.11.20160.96
21.11.20160.91
14.11.20160.87
07.11.20160.84
31.10.20160.90
24.10.20160.85
17.10.20160.84
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
3.29n/a
Market Capitalisation
in million USD
38n/a
Enterprise Value
in million USD
40n/a
Common Shares Outstanding
as per Aug 1, 2017
11,483,094n/a
Preferred Shares Outstanding
as per Aug 1, 2017
614,104n/a
Average Basic Shares Outstanding
TTM
10,267,249n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Medical Transcription Billing Corp is a healthcare information technology company that provides suite of proprietary web-based solutions, together with related business services to healthcare providers.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 30n/a
Gross Profit 12n/a
Operating Income -9n/a
EBITDA -3n/a
Net Profit -11n/a
Balance Sheet
Cash and Cash Equivalents 6n/a
Receivables 3n/a
Total Current Assets 10n/a
PP&E 1n/a
Total Assets 27n/a
Accounts Payable 1n/a
Current Debt 7n/a
Total Current Liabilities 14n/a
Long-Term Debt 1n/a
Total Liabilities 16n/a
Total Equity 11n/a
Cash Flow
Depreciation & Amortisation 6n/a
Change in Working Capital 1n/a
Operating Cash Flow -1n/a
Net Change in PP&E and Intangibles -1n/a
Investing Cash Flow -1n/a
Dividends Paid -1n/a
Financing Cash Flow 1n/a
Total Change in Cash -1n/a
Free Cash Flow -3n/a
Profitability Ratios
Gross Margin 39.6%n/a
Operating Margin -28.8%n/a
Net Profit Margin -32.9%n/a
Return on Equity -87.9%n/a
Return on Assets -36.8%n/a
Per Share Figures
Basic EPS -1.07n/a
Diluted EPS n/a
Sales per Share 2.94n/a
Book Value per Share 1.10n/a
FCF per Share -0.32n/a
Dividends per Share 0.08n/a
Price Multiples
Price to Earnings Ratio -3.08n/a
Price to Sales Ratio 1.12n/a
Price to Book Value 2.99n/a
Price to Free Cash Flow -10.21n/a
Valuation Metrics
EV/EBITDA -13.14n/a
EV/Sales 1.32n/a
Book to Market Value 0.30n/a
Other Ratios
Current Ratio 70.7%n/a
Liabilities to Equity Ratio 138.6%n/a
Debt to Assets Ratio 29.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Revenue
10
18
23
24
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-4
-11
-12
-13
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
6
8
11
11
Other Operating Income
0
0
0
0
Operating Expenses
-6
-14
-18
-20
Selling, General & Administrative
-5
-10
-12
-14
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
0
-1
-1
-1
Depreciation & Amortization
-1
-3
-5
-5
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
0
-6
-6
-9
Non-Operating Income (Loss)
0
0
0
-1
Interest Expense, net
0
0
0
-1
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
Pretax Income (Loss), Adjusted
0
-6
-6
-9
Abnormal Gains (Losses)
0
2
2
1
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
0
-4
-5
-9
Income Tax (Expense) Benefit, net
0
0
0
0
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
0
-5
-5
-9
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
0
-5
-5
-9
Minority Interest
0
0
0
0
Net Income
0
-5
-5
-9
Preferred Dividends
0
0
0
-1
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
0
-5
-5
-10
Remarks
restated on Mar 31, 2015 n/a
calculated values,
restated on Mar 24, 2016 n/a
calculated values,
restated on Mar 31, 2017 n/a
calculated values,
restated on Mar 31, 2017 n/a
calculated values,
Balance SheetBS data quality: 79% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
0
1
8
3
Cash & Cash Equivalents
0
1
8
3
Short Term Investments
0
0
0
0
Accounts & Notes Receivable
1
3
2
4
Accounts Receivable, Net
1
3
2
4
Notes Receivable, Net
0
0
0
0
Unbilled Revenues
0
0
0
0
Inventories
0
0
0
0
Raw Materials
0
0
0
0
Work In Process
0
0
0
0
Finished Goods
0
0
0
0
Other Inventory
0
0
0
0
Other Short Term Assets
0
1
1
1
Prepaid Expenses
0
1
1
1
Derivative & Hedging Assets
0
0
0
0
Assets Held-for-Sale
0
0
0
0
Deferred Tax Assets
0
0
0
0
Income Taxes Receivable
0
0
0
0
Discontinued Operations
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
Total Current Assets
2
5
11
8
Property, Plant & Equipment, Net
1
1
1
2
Property, Plant & Equipment
0
0
0
0
Accumulated Depreciation
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
Long Term Investments
0
0
0
0
Long Term Marketable Securities
0
0
0
0
Long Term Receivables
0
0
0
0
Other Long Term Assets
3
17
14
18
Intangible Assets
2
8
5
6
Goodwill
0
9
9
12
Other Intangible Assets
0
0
0
0
Prepaid Expense
0
0
0
0
Deferred Tax Assets
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
Prepaid Pension Costs
0
0
0
0
Discontinued Operations
0
0
0
0
Investments in Affiliates
0
0
0
0
Miscellaneous Long Term Assets
2
0
0
0
Total Noncurrent Assets
4
19
16
20
Total Assets
6
23
27
28
Liabilities and owners' equity
Payables & Accruals
1 1409086
3 3185906
2 1818048
5 5370856
Accounts Payable
0 200469
1 1082342
0 370441
2 1905131
Accrued Taxes
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 159236
0 202579
Other Payables & Accruals
1 1208617
2 2103564
1 1288371
3 3263146
Short Term Debt
1 916104
1 1066705
1 1082023
8 7848126
Short Term Borrowings
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
Other Short Term Liabilities
1 1083353
4 3891514
3 2858067
3 2638580
Deferred Revenue
0 56686
0 37508
0 73520
0 41666
Derivatives & Hedging
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
1 1026667
4 3854006
3 2784547
3 2596914
Total Current Liabilities
3 3408543
8 8144125
6 5758138
16 15857562
Long Term Debt
3 2569854
0 48564
5 4902923
4 4199852
Long Term Borrowings
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
Other Long Term Liabilities
1 615565
1 593974
1 1123887
1 1199461
Accrued Liabilities
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
Deferred Revenue
0 54736
0 42631
0 36082
0 26673
Deferred Tax Liabilities
0 41829
0 0
0 171269
0 345530
Derivatives & Hedging
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
1 519000
1 551343
1 916536
1 827258
Total Noncurrent Liabilities
3 3185419
1 642538
6 6026810
5 5399313
Total Liabilities
7 6593962
9 8786663
12 11784948
21 21256875
Preferred Equity
0 0
0 0
0 232
0 295
Share Capital & Additional Paid-In Capital
0 256730
19 18989688
25 24560235
26 26048856
Common Stock
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 -122031
-1 -662000
Retained Earnings
0 49121
-4 -4460129
-9 -9147507
-18 -17944230
Other Equity
0 -187354
0 -208962
0 -398979
0 -376090
Equity Before Minority Interest
0 118497
14 14320597
15 14891950
7 7066831
Minority Interest
0 0
0 0
0 0
0 0
Total Equity
0 118497
14 14320597
15 14891950
7 7066831
Total Liabilities & Equity
7 6712459
23 23107260
27 26676898
28 28323706
Remarks restated on Mar 31, 2015 n/a restated on Mar 24, 2016 n/a restated on Mar 31, 2017 n/a restated on Aug 3, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Net Income/Starting Line
0
-5
-5
-9
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
1
3
5
5
Non-Cash Items
0
1
1
3
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
0
-2
-3
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
1
-3
-2
-1
Change in Fixed Assets & Intangibles
0
-1
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-12
0
-3
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
0
17
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-1
5
-1
-4
Dividends Paid
0
0
0
-1
Cash From (Repayment of) Debt
0
-1
5
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
0
0
5
1
Increase in Capital Stock
0
0
5
1
Decrease in Capital Stock
0
0
0
-1
Other Financing Activities
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
0
-1
10
0
Net Cash Before Disc. Operations and FX
0
1
7
-5
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
0
1
7
-5
Effect of Foreign Exchange Rates
0
0
0
0
Net Changes in Cash
0
1
7
-5
Remarks
restated on Mar 31, 2015 n/a
calculated values,
restated on Mar 24, 2016 n/a
calculated values,
restated on Mar 31, 2017 n/a
calculated values,
restated on Mar 31, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo